文献速递关节外科

双动髋臼假体用于初次全髋关节置换术的成本效果:基于计算机的成本效用模型

The Cost-Effectiveness of Dual Mobility Implants for Primary Total Hip Arthroplasty: A Computer-Based Cost-Utility Model.
PubMed 文献 · J Bone Joint Surg Am · 2017-01-01

研究采用Markov模型从社会视角分析双动(DM)假体与常规假体在初次全髋关节置换术中的成本效果。基础分析中DM假体成本更低(39,008美元 vs 40,031美元)且效用更高(13.18 vs 13.13 QALYs),显示绝对优势。DM假体植入物成本超过常规假体1,023美元时不再节约成本,成本效果阈值为DM假体比常规假体贵5,287美元;当任何不可预见失败机制的年化增量翻修概率超过0.29%时DM不再具有成本效果。

要点

  • 基础分析中DM全髋关节置换术较常规全髋关节置换术成本更低且效用更高,显示绝对优势。
  • DM假体成本超过常规假体1,023美元时不再节约成本,成本效果阈值为DM假体比常规假体贵5,287美元。
  • 任何不可预见失败机制的年化增量翻修概率超过0.29%时DM不再具有成本效果。

核心结论

  • 该模型确定,从社会视角看,若新一代DM假体满足特定经济和临床基准,DM假体用于常规初次全髋关节置换术可节约成本。
  • 这些阈值与其他当代轴承的性能之间的差异往往相当窄。
  • 结果可能应用于新一代DM组件的上市后监测。

研究设计与样本

  • Markov模型分析,从社会视角纳入直接和间接成本。
  • 成本以2013年美元表示,来源于文献、全国住院患者样本和医疗保险与医疗补助服务中心。
  • 效果以质量调整生命年(QALYs)表示,模型填充了来自既往发表文献的健康状态效用和状态转移概率。
  • 分析针对患者终生进行,成本和效果按每年3%贴现。

主要发现

  • 基础分析中,DM全髋关节置换术显示绝对优势:累积成本39,008美元 vs 常规全髋关节置换术40,031美元,累积效用13.18 QALYs vs 13.13 QALYs,表明节约成本。
  • DM全髋关节置换术在其植入物成本超过常规全髋关节置换术1,023美元时不再节约成本。
  • DM假体的成本效果阈值为比常规假体高5,287美元。
  • 当任何不可预见失败机制的年化增量翻修概率超过0.29%时,DM不具有成本效果。
  • 假体内脱位概率对模型结果影响最大。

关键数值与推荐

  • 主要结局为增量成本效果比(ICER),支付意愿阈值为100,000美元/QALY。
  • DM全髋关节置换术在其植入物成本超过常规全髋关节置换术1,023美元时不再节约成本。
  • DM假体的成本效果阈值为比常规假体高5,287美元。
  • 当任何不可预见失败机制的年化增量翻修概率超过0.29%时,DM不具有成本效果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Dislocation remains a clinically important problem following primary total hip arthroplasty, and it is a common reason for revision total hip arthroplasty. Dual mobility (DM) implants decrease the risk of dislocation but can be more expensive than conventional implants and have idiosyncratic failure mechanisms. The purpose of this study was to investigate the cost-effectiveness of DM implants compared with conventional bearings for primary total hip arthroplasty. METHODS: Markov model analysis was conducted from the societal perspective with use of direct and indirect costs. Costs, expressed in 2013 U.S. dollars, were derived from the literature, the National Inpatient Sample, and the Centers for Medicare & Medicaid Services. Effectiveness was expressed in quality-adjusted life years (QALYs). The model was populated with health state utilities and state transition probabilities derived from previously published literature. The analysis was performed for a patient's lifetime, and costs and effectiveness were discounted at 3% annually. The principal outcome was the incremental cost-effectiveness ratio (ICER), with a willingness-to-pay threshold of $100,000/QALY. Sensitivity analyses were performed to explore relevant uncertainty. RESULTS: In the base case, DM total hip arthroplasty showed absolute dominance over conventional total hip arthroplasty, with lower accrued costs ($39,008 versus $40,031 U.S. dollars) and higher accrued utility (13.18 versus 13.13 QALYs) indicating cost-savings. DM total hip arthroplasty ceased being cost-saving when its implant costs exceeded those of conventional total hip arthroplasty by $1,023, and the cost-effectiveness threshold for DM implants was $5,287 greater than that for conventional implants. DM was not cost-effective when the annualized incremental probability of revision from any unforeseen failure mechanism or mechanisms exceeded 0.29%. The probability of intraprosthetic dislocation exerted the most influence on model results. CONCLUSIONS: This model determined that, compared with conventional bearings, DM implants can be cost-saving for routine primary total hip arthroplasty, from the societal perspective, if newer-generation DM implants meet specific economic and clinical benchmarks. The differences between these thresholds and the performance of other contemporary bearings were frequently quite narrow. The results have potential application to the postmarket surveillance of newer-generation DM components. LEVEL OF EVIDENCE: Economic and decision analysis Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Barlow BT, McLawhorn AS, Westrich GH, et al. The Cost-Effectiveness of Dual Mobility Implants for Primary Total Hip Arthroplasty: A Computer-Based Cost-Utility Model. J Bone Joint Surg Am. 2017. PMID: 28463921. doi:10.2106/JBJS.16.00109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。